Allogene Therapeutics logo

Allogene Therapeutics

South San Francisco, CA

Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.

allogene.com

Company Details

Founded

2017

Employees

Between 200 - 500 employees

Raised

$1,011,770,368

Headquarters Location

South San Francisco, CA

Public

Yes

Acquired

No

CEO

David ChangDavid Chang

Founders

Arie Belldegrun
Arie Belldegrun
David Chang
David Chang
Joshua Kazam
Joshua Kazam

Company Collections

These are collections Allogene Therapeutics is a part of. Click on the collection name to view similar companies.

Allogene Therapeutics' Tech Stack